US OptionsDetailed Quotes

ARQT241220P10000

Watchlist

0.25
-0.10-28.57%

15min DelayClose Nov 27 16:00 ET

0.44High0.25Low

Arcutis Biotherapeutics Stock Discussion

Jaguar8

Nov 13 16:07

13G

$Arcutis Biotherapeutics (ARQT.US)$
Arcutis Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rubric Capital Management LP(9.38%),David Rosen(9.38%)

MommaCrazy

Oct 22 18:50

$Arcutis Biotherapeutics (ARQT.US)$ Blackrock bought over 9mil shares today.

MommaCrazy

Oct 20 20:26

$Arcutis Biotherapeutics (ARQT.US)$ This should rebound in the morning. 🙏
Long-term! 😜

Trytosaveabit

Oct 18 07:21

News

$Arcutis Biotherapeutics (ARQT.US)$ Arcutis Announces Health Canada Approval of ZORYVE® (Roflumilast) Foam 0.3% to Treat Seborrheic Dermatitis in Individuals 9 Years of Age and Older
1 MINUTE AGO, 8:20 AM EDT
VIA GLOBENEWSWIRE

Rocketier (MAXN)

Oct 3 13:14

$Arcutis Biotherapeutics (ARQT.US)$ Shorts will suffer

Teddy123

Sep 25 00:03

New Data Shows ZORYVE® (Roflumilast) Cream 0.15% Provided Consistent Improvement of Atopic Dermatitis in Individuals With Diverse Skin Types

$Arcutis Biotherapeutics (ARQT.US)$
New Data Shows ZORYVE® (Roflumilast) Cream 0.15% Provided Consistent Improvement of Atopic Dermatitis in Individuals With Diverse Skin Types | ARQT Stock News

demonandevil

Sep 4 09:59

$Arcutis Biotherapeutics (ARQT.US)$ keep testing high

demonandevil

Aug 29 09:49

$Arcutis Biotherapeutics (ARQT.US)$ 11 , going to moon

Trytosaveabit

Aug 28 07:21

Update

$Arcutis Biotherapeutics (ARQT.US)$ Arcutis Biotherapeutics Inc -No New Safety Signals Observed During 56 Weeks of Treatment! Plans to submit sNDA to FDA in Q1 2025

103387577

Aug 19 10:19

easy

Share Your Profit/Loss

No comment yet